144 related articles for article (PubMed ID: 38414346)
1. Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis-Results of an in vitro investigation.
Schaller M; Walker B; Nabhani S; Odon A; Riel S; Jäckel A
Mycoses; 2024 Mar; 67(3):e13710. PubMed ID: 38414346
[TBL] [Abstract][Full Text] [Related]
2. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
Jaiswal A; Sharma RP; Garg AP
Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
[TBL] [Abstract][Full Text] [Related]
3. In vitro determination of the combination of ciclopirox and terbinafine in the treatment of dermatophytosis.
da Costa B; Pippi B; Chaves M; Agostineto G; Fuentefria AM
J Mycol Med; 2024 Mar; 34(1):101464. PubMed ID: 38367460
[TBL] [Abstract][Full Text] [Related]
4. Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
Seidl HP; Jäckel A; Müller J; Schaller M; Borelli C; Polak A
Mycoses; 2015 Oct; 58(10):610-9. PubMed ID: 26334024
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Jo Siu WJ; Tatsumi Y; Senda H; Pillai R; Nakamura T; Sone D; Fothergill A
Antimicrob Agents Chemother; 2013 Apr; 57(4):1610-6. PubMed ID: 23318803
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.
Baran R; Feuilhade M; Combernale P; Datry A; Goettmann S; Pietrini P; Viguie C; Badillet G; Larnier C; Czernielewski J
Br J Dermatol; 2000 Jun; 142(6):1177-83. PubMed ID: 10848743
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen and nitrogen species are crucial for the antifungal activity of amorolfine and ciclopirox olamine against the dermatophyte Trichophyton interdigitale.
Carmo PHF; Freitas GJC; Dornelas JCM; Almeida BCT; Baltazar LM; Ferreira GF; Peres NTA; Santos DA
Med Mycol; 2022 Aug; 60(8):. PubMed ID: 35896502
[TBL] [Abstract][Full Text] [Related]
9. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
[TBL] [Abstract][Full Text] [Related]
10. [Onychocola canadensis Sigler in onychomycosis : A new dermatophyte-like mould in Germany].
Nenoff P; Schorlemmer B; Uhrlaß S; Baunacke A; Baunacke A; Friedrichs C; Iffländer J; Syhre E; Schneider A; Krüger C; Maier T
Hautarzt; 2016 Sep; 67(9):739-49. PubMed ID: 26758910
[TBL] [Abstract][Full Text] [Related]
11. Visualisation of penetration of topical antifungal drug substances through mycosis-infected nails by matrix-assisted laser desorption ionisation mass spectrometry imaging.
Endringer Pinto F; Bagger C; Kunze G; Joly-Tonetti N; Thénot JP; Osman-Ponchet H; Janfelt C
Mycoses; 2020 Aug; 63(8):869-875. PubMed ID: 32406142
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
Tatsumi Y; Yokoo M; Senda H; Kakehi K
Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679
[TBL] [Abstract][Full Text] [Related]
14. Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.
Matsuda Y; Sugiura K; Hashimoto T; Ueda A; Konno Y; Tatsumi Y
PLoS One; 2016; 11(7):e0159661. PubMed ID: 27441843
[TBL] [Abstract][Full Text] [Related]
15. A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
Blume-Peytavi U; Tosti A; Falqués M; Tamarit ML; Carreño C; Galván J; Tebbs V
Mycoses; 2022 Apr; 65(4):392-401. PubMed ID: 34752667
[TBL] [Abstract][Full Text] [Related]
16. Onychomycosis: clinical, mycological and in vitro susceptibility testing of isolates of Trichophyton rubrum.
Azambuja CV; Pimmel LA; Klafke GB; Xavier MO
An Bras Dermatol; 2014; 89(4):581-6. PubMed ID: 25054744
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Gupta AK; Gregurek-Novak T
Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
19. Onychomycosis.
Welsh O; Vera-Cabrera L; Welsh E
Clin Dermatol; 2010 Mar; 28(2):151-9. PubMed ID: 20347657
[TBL] [Abstract][Full Text] [Related]
20. Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum.
Ghelardi E; Celandroni F; Gueye SA; Salvetti S; Senesi S; Bulgheroni A; Mailland F
Antimicrob Agents Chemother; 2014 May; 58(5):2825-9. PubMed ID: 24614379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
